An Unbalanced Exon-Expression qPCR-based Assay for Detection of ALK Translocation (Fusion) in Lung Cancer

Journal Title: Pulmonary Research and Respiratory Medicine – Open Journal - Year 2017, Vol 4, Issue 1

Abstract

Non-Small Cell Lung Cancer (NSCLC) constitutes 85-90% of all lung cancer. Accurate diagnosis and selection of targeted therapies in lung cancer depends on robust detection of the molecular events that underlie its pathogenesis. Since patients having a rearrangement in the Anaplastic Lymphoma Kinase (ALK) gene respond well to treatment with crizotinib, identification of such ALK mutations is necessary for the successful treatment of NSCLC. The most common rearrangement of the ALK gene in NSCLC involves fusion with echinoderm microtubule-associated protein-like 4 (EML 4) as the upstream partner. Current testing methods for this rearrangement (IHC and/or FISH) can be very subjective due to high operator variability. They require expert interpretation by a pathologist and have a long turnaround time. The FDAapproved Fluorescence In Situ Hybridization (FISH) test has been shown to lack sensitivity and is generally acknowledged to fail to detect rearrangements in up to 60% of patients. Here, we have adapted an approach described earlier and optimized it for use with degraded RNA obtained from Formalin-Fixed Paraffin-Embedded (FFPE) sections. This method is based on the unbalanced expression of 5’- and 3’-regions (exons) of the ALK gene. It is also applicable to the detection of other cancer-relevant gene rearrangements e.g. ROS 1 or RET that result in increased expression of the 3’-kinase domain. Patients with these rearrangements have been shown to respond to crizotinib and cabozantinib, respectively. Using NSCLC cell lines we demonstrate that our method is cost-effective, reproducible, sensitive, objective, and easy to use. Unlike FISH, it does not require interpretation by several scorers and it can be performed in any clinical laboratory with access to a qPCR instrument. Here we present the protocol for the method and validation with 197 clinical samples.

Authors and Affiliations

Rama K. Singh

Keywords

Related Articles

The Relationship between Peripheral Arterial Disease and Chronic Obstructive Pulmonary Disease

Chronic obstructive pulmonary disease (COPD) is a representative chronic pulmonary disease and is predicted to become the third leading cause of death in middle-income countries by 2030.1 COPD has been recognized not on...

A Diagnostic Tool Yet Simple and Strong: Inspection of the Jugular Veins

Inspection of the neck, including the inspection of veins is taught at most of the medical schools as a routine step of physical examination. However, rarely we see students assess findings in a correct fashion, or even...

Modern Technology in Respiratory Medicine: Lung Ultrasonography–Is it Time for the Stethoscope to Give Up its Throne?

The year 2016 marks the 200th anniversary of the invention of the stethoscope by Dr. Réne Théophile Hyacinthe Laennec. He was first inspired in September 1816 when he observed 2 children playing with a long piece of soli...

Allergic Rhinitis and Asthma: The United Airways Disease

Interactions between the upper and lower airways have been well investigated in the past 30 years. The nasal and bronchial mucosa share similarities, in addition to their functional interaction. At least 80% of asthmatic...

Utility of a Sticky Note “Post-it” and a Cotton Swab as a Tool to Aid Cardiac Examination

A 68-year-old woman was admitted to our hospital because of worsening dyspnea on exertion for one week. She had been treated with supplemental oxygen with nasal cannula (0.25 L/ min at rest and 0.5 L/min during exercise)...

Download PDF file
  • EP ID EP546428
  • DOI 10.17140/PRRMOJ-4-132
  • Views 181
  • Downloads 0

How To Cite

Rama K. Singh (2017). An Unbalanced Exon-Expression qPCR-based Assay for Detection of ALK Translocation (Fusion) in Lung Cancer. Pulmonary Research and Respiratory Medicine – Open Journal, 4(1), 9-18. https://europub.co.uk/articles/-A-546428